CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Praxis Precision Medicines, Inc. - PRAX CFD

57.38
0.16%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.39
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 57.47
Open 57.48
1-Year Change 6147.83%
Day's Range 57.25 - 58.06
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 57.31 0.40 0.70% 56.91 58.84 56.90
Jul 24, 2024 57.04 0.35 0.62% 56.69 59.32 55.94
Jul 23, 2024 58.03 3.07 5.59% 54.96 58.31 54.94
Jul 22, 2024 56.99 1.88 3.41% 55.11 58.34 54.34
Jul 19, 2024 54.56 0.47 0.87% 54.09 56.41 53.49
Jul 18, 2024 53.81 -1.59 -2.87% 55.40 57.25 52.86
Jul 17, 2024 55.09 3.15 6.06% 51.94 55.34 50.62
Jul 16, 2024 52.90 3.95 8.07% 48.95 53.52 48.95
Jul 15, 2024 50.91 0.09 0.18% 50.82 52.17 49.94
Jul 12, 2024 50.73 0.78 1.56% 49.95 51.07 48.25
Jul 11, 2024 49.85 1.88 3.92% 47.97 50.93 47.10
Jul 10, 2024 47.71 1.72 3.74% 45.99 47.92 45.49
Jul 9, 2024 45.84 3.89 9.27% 41.95 46.89 41.90
Jul 8, 2024 42.22 2.30 5.76% 39.92 42.46 39.25
Jul 5, 2024 40.26 0.31 0.78% 39.95 40.68 38.82
Jul 3, 2024 39.80 0.45 1.14% 39.35 40.20 38.84
Jul 2, 2024 39.22 -1.12 -2.78% 40.34 41.00 38.79
Jul 1, 2024 41.12 1.16 2.90% 39.96 41.76 39.60
Jun 28, 2024 41.17 1.44 3.62% 39.73 42.16 39.13
Jun 27, 2024 39.50 -0.45 -1.13% 39.95 40.91 38.41

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Praxis Precision Medicines, Inc. Company profile

About Praxis Precision Medicines Inc

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance. Its development stage products include PRAX-114, PRAX-944 and PRAX-562. PRAX-114 is an extrasynaptic-preferring gamma-aminobutyric acid-A (GABAA) receptor positive allosteric modulator (PAM) for the treatment of patients suffering from major depressive disorder (MDD) and perimenopausal depression (PMD). PRAX-944 is a differentiated selective small molecule inhibitor of T-type calcium channel, for the treatment of essential tremor (ET). PRAX-562 is the selective, persistent sodium current blocker in development for the treatment of a range of CNS disorders.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Praxis Precision Medicines Inc revenues was not reported. Net loss applicable to common stockholders increased from $70.3M to $167.1M. Higher net loss reflects Stock based compensation increase from $43.6M to $89.2M (expense), General and administrative increase from $13.1M to $33.7M (expense), Stock-based Compensation in SGA increase from $3.9M to $13.3M (expense).

Industry: Biotechnology & Medical Research (NEC)

99 High Street, 30th Floor
BOSTON
MASSACHUSETTS 02110
US

People also watch

BTC/USD

68,006.70 Price
+4.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,387.21 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.60

ETH/USD

3,280.77 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading